Navigation Links
Lung Disease-Pipeline Insights, 2014
Date:9/3/2014

NEW YORK, Sept. 3, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Lung Disease-Pipeline Insights, 2014

http://www.reportlinker.com/p02278634/-Lung-Disease-Pipeline-Insights-2014.html

SUMMARY
DelveInsight's," Lung Disease-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Lung Disease. This report provides information on the therapeutic development based on the Lung Disease dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Lung Disease
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Lung Disease pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Lung Disease and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Lung Disease
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Lung Disease pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions
Table of Contents
- Lung Disease Overview
- Lung Disease Pipeline Therapeutics

- Lung Disease Therapeutics under Development by Companies
- Lung Disease Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Lung Disease Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Lung Disease Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Lung Disease Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Lung Disease – Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Lung Disease – Discontinued Products
- Lung Disease – Dormant Products
- Companies Involved in Therapeutics Development for Lung Disease
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Lung Disease, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Lung Disease Assessment by Monotherapy Products
- Lung Disease Assessment by Combination Products
- Lung Disease Assessment by Route of Administration
- Lung Disease Assessment by Stage and Route of Administration
- Lung Disease Assessment by Molecule Type
- Lung Disease Assessment by Stage and Molecule Type
- Lung Disease Therapeutics – Discontinued Products
- Lung Disease Therapeutics – Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Lung Disease, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Lung Disease Assessment by Monotherapy Products
- Lung Disease Assessment by Combination Products
- Lung Disease Assessment by Route of Administration
- Lung Disease Assessment by Stage and Route of Administration
- Lung Disease Assessment by Molecule Type
- Lung Disease Assessment by Stage and Molecule Type

To order this report: Lung Disease-Pipeline Insights, 2014
http://www.reportlinker.com/p02278634/-Lung-Disease-Pipeline-Insights-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Adenocarcinoma-Pipeline Insights, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... Aug. 3, 2017  Agragen, LLC, a ... in the biopharmaceutical, nutraceutical, and aquacultural feed sectors, ... its lead drug candidates, AGR131.  This drug is ... from the blood of patients suffering from inflammatory ... bowel disease. ...
(Date:8/2/2017)... Aug. 2, 2017  Life Flight Network and PeaceHealth Oregon ... improves patient care and operational efficiency for patients at hospitals ... , Cottage Grove , and ... PeaceHealth and Life Flight Network work collaboratively to move patients ... or when a time sensitive emergency exists. ...
(Date:7/31/2017)... Three Tru-D SmartUVC robots have arrived at Brian Allgood Army ... short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 germ-killing robot that ... professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at Army hospitals ... "Although the BAACH has a very low infection rate, below ...
Breaking Medicine Technology:
(Date:8/18/2017)... Raton (PRWEB) , ... August 18, 2017 , ... Alcovit, ... continuing to ramp up its marketing efforts with its product now available through Jet.com. ... remedy to the public. The effervescent powdered drink is designed to quickly detox the ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Three Narrow Roads”: a vivid and provocative look ... author, Rev. Dr. Burnett King Sr., is currently the pastor-teacher-visionary at Simply the WORD ... Track Club, Inc., a track-and-field program geared towards youth. , King shares, “When I ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Prompted By Love”: a ... creation of published author, Mary Nettles. Author Mary P. Nettles has devoted her ... assistant VBS teacher. Her lifelong desire to write was, however, not fulfilled until ...
(Date:8/17/2017)... ... 17, 2017 , ... The award-winning producers of the Innovations ... Council for Therapeutic Recreation Certification (NCTRC), slated to air nationwide, fourth quarter 2017. ... a non-profit, international organization dedicated to professional excellence for the protection of consumers ...
(Date:8/17/2017)... ... August 17, 2017 , ... The line-up includes voices from all sectors ... a dental practice in a competitive market environment where Corporate Dentistry is making inroads. ... transform you and your practice.” says Daniel A. ‘Danny’ Bobrow, AIM Dental Marketing’s president, ...
Breaking Medicine News(10 mins):